Pfizer Inc. researchers concluded last year that pregnant women taking Zoloft risked having babies with heart defects, according to evidence made public by a lawyer at the first trial of more than 1,000 lawsuits over the drug.
Pfizer Inc. (NYSE:PFE) has yet another victory to add to its long list of successes in the healthcare sector. Its lung cancer drug Xalkori has been granted "Breakthrough Therapy Designation" by the US Food and Drug Administration (FDA) for the ...
Pfizer Inc. (NYSE:PFE) and Provectus Biopharmaceuticals Inc (NYSEMKT:PVCT) today received approval from the US Patent Office for a joint patent application filed by the two companies for their investigational cancer drug, PV-10.
Pfizer Inc. (NYSE:PFE) ended the past week on a positive note as a court ruled that the company's antidepressant Zoloft did not cause birth defects in children born to mothers who took the pill during pregnancy.